Effect of polyethylene glycol modification on the circulatory stability and immunogenicity of recombinant human butyrylcholinesterase

Chemico-Biological Interactions

Volumn 175, Issue 1-3, 2008, Pages 255-260

  Chilukuri, Nageswararao ^a   Sun, Wei ^a   Naik, Ramachandra S ^a   Parikh, Kalpana ^a   Tang, Lin ^a   Doctor, Bhupendra P ^a   Saxena, Ashima ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Bioscavenger; Circulatory stability; Monomeric butyrylcholinesterase; Organophosphorus compounds; Polyethylene glycosylation

Indexed keywords

BUTYRYLTHIOCHOLINE; CHOLINESTERASE; MACROGOL; ORGANOPHOSPHORUS COMPOUND; RECOMBINANT ENZYME;

ADENOVIRUS; ANIMAL EXPERIMENT; ARTICLE; CATALYSIS; CHEMICAL MODIFICATION; CHEMICAL WARFARE; EMBRYO; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME KINETICS; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOGENICITY; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; VIRUS RECOMBINANT;

BUTYRYLCHOLINESTERASE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS;

ADENOVIRIDAE; MUS;

EID: 50649120602     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.05.020     Document Type: Article

References (25)

1. Taylor P. Anticholinesterase agents. In: Gilman A.G., Rall T.W., Nies A.S., and Taylor P. (Eds). The Pharmacological Basis of Therapeutics (1990), Macmillan, New York 131
2. Heffron P.F., and Hobbinger F. Relationship between inhibition of acetylcholinesterase and response of the rat phrenic nerve-diaphragm preparation to indirect stimulation at higher frequencies. Brit. J. Pharmacol. 66 (1979) 323-329
3. Stewart W.C., and Anderson E.A. Effects of a cholinesterase inhibitor when injected into the medulla of the rabbit. J. Pharmacol. Exp. Ther. 162 (1968) 309-318
4. Stewart W.C. The effects of sarin and atropine on the respiratory center and neuromuscular junctions of the rat. Can. J. Biochem. Physiol. 37 (1959) 651-660
5. Heath A.J.W., and Meredith T. Atropine in the management of anticholinesterase poisoning. In: Ballantyne B., and Marrs T.C. (Eds). Clinical and Experimental Toxicology of Organophosphates and Carbamates (1992), Butterworth, Oxford 543
6. Wilson I.B., and Ginsburg S.A. A powerful reactivator of alkyl phosphate-inhibited acetylcholinesterase. Biochim. Biophys. Acta 18 (1955) 168-170
7. Gordon J.J., Leadbeater L., and Maidment M.P. The protection of animals against organophosphorous poisoning by pretreatment with a carbamate. Toxicol. Appl. Pharmacol. 43 (1978) 207-216
8. Doctor B.P., and Saxena A. Bioscavengers for the protection of humans against organophosphate toxicity. Chem. Biol. Interact. 157/158 (2005) 167-171
9. Ashani Y., Shapira S., Levy D., Wolfe A.D., Doctor B.P., and Raveh L. Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice. Biochem. Pharmacol. 41 (1991) 37-41
10. Raveh L., Grunwald J., Marcus D., Papier Y., Cohen E., and Ashani Y. Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity. Biochem. Pharmacol. 45 (1993) 2465-2474
11. Brandeis R., Raveh L., Grunwald J., Cohen E., and Ashani Y. Prevention of soman-induced cognitive deficits by pretreatment with human butyrylcholinesterase in rats. Pharmacol. Biochem. Behav. 46 (1993) 889-896
12. Raveh L., Grauer E., Grunwald J., Cohen E., and Ashani Y. The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase. Toxicol. Appl. Pharmacol. 145 (1997) 43-53
13. Allon N., Raveh L., Gilat E., Cohen E., Grunwald J., and Ashani Y. Prophylaxis against soman inhalation toxicity in guinea pigs by pretreatment alone with human serum butyrylcholinesterase. Toxicol. Sci. 43 (1998) 121-128
14. Lenz D.E., Maxwell D.M., Koplowitz I., Clark C.R., Capacio B.R., Cerasoli D.M., Federko J.M., Luo C., Saxena A., Doctor B.P., and Olson C. Protection against soman poisoning by human butyrylcholinesterase in guinea pigs and cynomolgous monkeys. Chem. Biol. Interact. 157/158 (2005) 205-210
15. Lockridge O., Eckerson H.W., and La Du B.N. Interchain disulfide bonds and subunit organization in human serum cholinesterase. J. Biol. Chem. 25 (1979) 8324-8333
16. Duysen E.G., Bartles C.F., and Lockridge O. Wild-type and A328W mutant human butyrylcholinesterase tetramers expressed in Chinese hamster ovary cells have a 16-h half-life in the circulation and protect mice from cocaine toxicity. J. Pharmacol. Exper. Ther. 302 (2002) 751-758
17. Chilukuri N., Parikh K., Naik R., Sun W., Tipparaju P., Doctor B.P., and Saxena A. Polyethylene glycosylation prolongs the circulatory stability of recombinant human butyrylcholinesetrase. Chem. Biol. Interact. 157/158 (2005) 115-121
18. Huang Y.J., Huang Y., Baldassarre H., Wang B., Lazaris A., Leduc M., Bilodeau A.S., Bellemare A., Cote M., Herskovits P., Touati M., Turcotte C., Valeanu L., Lemee N., Wilgus H., Begin I., Bhatia B., Rao K., Neveu N., Brochu E., Pierson J., Hockley D.K., Cerasoli D.M., Lenz D.E., Karatzas C.N., and Langermann S. Recombinant human butyrylcholinesterase from milk of transgenic animals to protect against organophosphate poisoning. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 13603-13608
19. Doctor B.P., Toker L., Roth E., and Silman I. Microtiter assay for acetylcholinesterase. Anal. Biochem. 166 (1987) 399-403
20. Ellman G.L., Courtney A.D., Andres Jr. V., and Featherstone R.M. A new and rapid colorimetric determination of acetycholinesterase activity. Biochem. Pharmacol. 7 (1961) 88-95
21. Laub P.B., and Gallo J.M. NCOM-a Windows-based computer program for noncompartmental analysis of pharmacokinetic data. J. Pharma. Sci. 85 (1996) 393-395
22. Laemmli U.K. Cleavage of structural proteins during the assembly of head of bacteriophage T4. Nature 227 (1970) 680-685
23. Saxena A., Fedorko J.M., Vinayaka C.R., Medhekar R., Radić Z., Taylor P., Lockridge O., and Doctor B.P. Amino acid residues controlling the binding of (R,S)-1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methyl)piperidine hydrochloride (E2020) to cholinesterases. Eur. J. Biochem. 270 (2003) 4447-4458
24. DeForge L.E., and Remick D.G. Sandwich ELISA for detection of pictogram quantities of interleukin-8. Immunol. Invest. 20 (1991) 89-97
25. Charles S.A., Harris J.M., Pedder S., and Kumar S. Improving hepatitis C therapy; attaching polyethylene glycol "tail" to interferon for better clinical properties. Mod. Drug Discov. 5 (2000) 59-65